Chlamydia, Gonorrhea, and Incident HIV Infection During Pregnancy Predict Preterm Birth Despite Treatment.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
15 12 2021
Historique:
received: 11 02 2021
accepted: 19 05 2021
pubmed: 24 5 2021
medline: 27 1 2022
entrez: 23 5 2021
Statut: ppublish

Résumé

Identifying predictors of preterm birth (PTB) in high-burden regions is important as PTB is the leading cause of global child mortality. This analysis was nested in a longitudinal study of human immunodeficiency virus (HIV) incidence in Kenya. HIV-seronegative women enrolled in pregnancy had nucleic acid amplification tests (chlamydia and gonorrhea), rapid plasma reagin (syphilis), wet mount microscopy (Trichomonas and yeast), and Gram stain (bacterial vaginosis); sexually transmitted infection (STI) treatment was provided. PTB predictors were determined using log-binomial regression. Among 1244 mothers of liveborn infants, median gestational age at enrollment was 26 weeks (IQR, 22-31), and at delivery was 39.1 weeks (IQR, 37.1-40.9). PTB occurred in 302 women (24.3%). Chlamydia was associated with a 1.59-fold (P = .006), gonorrhea a 1.62-fold (P = .04), and incident HIV a 2.08-fold (P = .02) increased PTB prevalence. Vaginal discharge and cervical inflammation were associated with PTB, as were age ≤21 (prevalence ratio [PR] = 1.39, P = .001) and any STI (PR = 1.47, P = .001). Associations with chlamydia and incident HIV remained in multivariable models. STIs and incident HIV in pregnancy predicted PTB despite treatment, suggesting the need for earlier treatment and interventions to decrease genital inflammation.

Sections du résumé

BACKGROUND
Identifying predictors of preterm birth (PTB) in high-burden regions is important as PTB is the leading cause of global child mortality.
METHODS
This analysis was nested in a longitudinal study of human immunodeficiency virus (HIV) incidence in Kenya. HIV-seronegative women enrolled in pregnancy had nucleic acid amplification tests (chlamydia and gonorrhea), rapid plasma reagin (syphilis), wet mount microscopy (Trichomonas and yeast), and Gram stain (bacterial vaginosis); sexually transmitted infection (STI) treatment was provided. PTB predictors were determined using log-binomial regression.
RESULTS
Among 1244 mothers of liveborn infants, median gestational age at enrollment was 26 weeks (IQR, 22-31), and at delivery was 39.1 weeks (IQR, 37.1-40.9). PTB occurred in 302 women (24.3%). Chlamydia was associated with a 1.59-fold (P = .006), gonorrhea a 1.62-fold (P = .04), and incident HIV a 2.08-fold (P = .02) increased PTB prevalence. Vaginal discharge and cervical inflammation were associated with PTB, as were age ≤21 (prevalence ratio [PR] = 1.39, P = .001) and any STI (PR = 1.47, P = .001). Associations with chlamydia and incident HIV remained in multivariable models.
CONCLUSIONS
STIs and incident HIV in pregnancy predicted PTB despite treatment, suggesting the need for earlier treatment and interventions to decrease genital inflammation.

Identifiants

pubmed: 34023871
pii: 6282455
doi: 10.1093/infdis/jiab277
pmc: PMC8672741
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2085-2093

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

J Matern Fetal Neonatal Med. 2010 Jun;23(6):563-8
pubmed: 19903113
Lancet. 2020 Jan 25;395(10220):285-293
pubmed: 31982074
Cochrane Database Syst Rev. 2018 Nov 14;11:CD012505
pubmed: 30480756
Obstet Gynecol. 1988 Jan;71(1):89-95
pubmed: 3336545
Infect Dis Obstet Gynecol. 2012;2012:157159
pubmed: 22505797
J Epidemiol Community Health. 2015 Sep;69(9):826-33
pubmed: 25911693
Cent Afr J Med. 2010 May-Aug;56(5-8):30-41
pubmed: 23457848
Syst Rev. 2015 Mar 21;4:31
pubmed: 25874659
BMC Res Notes. 2013 Feb 13;6:60
pubmed: 23402277
Sex Transm Dis. 2019 Jun;46(6):389-394
pubmed: 30762719
Sex Transm Dis. 2014 Jun;41(6):369-76
pubmed: 24825333
J Reprod Immunol. 2013 Mar;97(1):112-9
pubmed: 23312455
Lancet Infect Dis. 2018 Apr;18(4):452-460
pubmed: 29371067
Matern Child Health J. 2014 Oct;18(8):1795-802
pubmed: 24337865
Sex Transm Dis. 1997 Jul;24(6):353-60
pubmed: 9243743
PLoS One. 2019 Feb 27;14(2):e0211720
pubmed: 30811406
Bull World Health Organ. 2007 Jan;85(1):9-18
pubmed: 17242753
PLoS One. 2019 Jul 1;14(7):e0218349
pubmed: 31260486
Paediatr Perinat Epidemiol. 2019 Jan;33(1):88-99
pubmed: 30516287
Sex Transm Dis. 2016 Jun;43(6):382-7
pubmed: 27196260
J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):142-149
pubmed: 27828872
BMC Pregnancy Childbirth. 2017 Nov 8;17(Suppl 2):338
pubmed: 29143627
Infect Dis Obstet Gynecol. 2012;2012:430585
pubmed: 22829747
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
BMC Pregnancy Childbirth. 2010 Feb 23;10 Suppl 1:S2
pubmed: 20233383
Braz J Infect Dis. 2011 Nov-Dec;15(6):533-9
pubmed: 22218511
Adolesc Med State Art Rev. 2012 Apr;23(1):123-38, xi
pubmed: 22764559
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Sex Transm Dis. 2015 Nov;42(11):637-42
pubmed: 26462189
J Perinatol. 2002 Jun;22(4):315-23
pubmed: 12032796
Sex Transm Infect. 2013 Dec;89(8):672-8
pubmed: 24005255
Acta Obstet Gynecol Scand. 2015 Sep;94(9):989-96
pubmed: 26084843
BJOG. 2015 Mar;122(4):491-9
pubmed: 25414127
Obstet Gynecol. 2014 Oct;124(4):863-866
pubmed: 25244460
Cochrane Database Syst Rev. 2017 Sep 22;9:CD010485
pubmed: 28937705
Am J Reprod Immunol. 2004 Aug;52(2):174-83
pubmed: 15274659
Eur J Epidemiol. 2011 Jun;26(6):493-502
pubmed: 21538042
AIDS. 2015 Sep 24;29(15):2025-33
pubmed: 26352880
BMC Infect Dis. 2016 Jun 06;16:250
pubmed: 27268218
BMC Pregnancy Childbirth. 2014 Jan 08;14:7
pubmed: 24397463
Pediatr Infect Dis J. 2016 Aug;35(8):894-900
pubmed: 27164464
Am J Obstet Gynecol. 1998 Feb;178(2):374-80
pubmed: 9500502
J Infect Dis. 2002 Oct 1;186(7):940-7
pubmed: 12232834
Pediatrics. 1991 Jun;87(6):838-40
pubmed: 2034487
J Int AIDS Soc. 2019 Feb;22(2):e25257
pubmed: 30816632
Matern Child Health J. 2010 Nov;14(6):978-86
pubmed: 19795198
JAMA. 2020 Apr 7;323(13):1286-1292
pubmed: 32259236

Auteurs

Jayalakshmi Ravindran (J)

Department of Pediatrics, University of Washington, Seattle, Washington, USA.

Barbra A Richardson (BA)

Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Department of Global Health, University of Washington, Seattle, Washington, USA.

John Kinuthia (J)

Department of Global Health, University of Washington, Seattle, Washington, USA.
Kenyatta National Hospital, Nairobi, Kenya.

Jennifer A Unger (JA)

Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.

Alison L Drake (AL)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Lusi Osborn (L)

Kenyatta National Hospital, Nairobi, Kenya.

Daniel Matemo (D)

Kenyatta National Hospital, Nairobi, Kenya.

Janna Patterson (J)

Bill and Melinda Gates Foundation, Seattle, Washington, USA.

R Scott McClelland (RS)

Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Department of Medicine, University of Washington, Seattle, Washington, USA.

Grace John-Stewart (G)

Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Department of Global Health, University of Washington, Seattle, Washington, USA.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Department of Medicine, University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH